Our Pricing

Buy Private Weight Loss Injections Online UK

Published on: June 03, 2026

When you buy private weight loss injections online UK through Cured Pharmacy, you gain access to the latest MHRA-licensed GLP-1 treatments including Mounjaro, Wegovy, and Saxenda, with transparent pricing from £135.00 and a free clinical assessment completed in under three minutes. Our UK-registered prescribers assess your suitability for prescription weight loss injections, ensuring safe, evidence-based treatment tailored to your individual health profile.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists mimic naturally occurring hormones that regulate appetite and blood glucose levels. When you inject these medications subcutaneously once weekly (or daily for Saxenda), they bind to GLP-1 receptors in the brain's appetite centres, reducing hunger signals and slowing gastric emptying [1]. This dual mechanism helps you feel fuller for longer whilst consuming fewer calories.

Tirzepatide, the active ingredient in Mounjaro, represents a significant advancement as the first dual GIP/GLP-1 receptor agonist licensed in the UK. By activating both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways simultaneously, tirzepatide produces greater weight reduction than single-pathway medications [2]. In the SURMOUNT-1 trial, participants receiving the 15mg dose achieved an average 22.5% body weight reduction over 72 weeks, compared to 2.4% with placebo [2].

Semaglutide (found in Wegovy) and liraglutide (Saxenda) work through the GLP-1 pathway alone. The STEP 1 trial demonstrated that semaglutide 2.4mg weekly resulted in an average 14.9% weight loss over 68 weeks [3]. Liraglutide, administered daily at 3mg, produced an average 8% weight reduction in the SCALE trial over 56 weeks [4]. All three medications require prescription and clinical monitoring throughout treatment.

Comparing Weight Loss Injections Available at Cured Pharmacy

Mounjaro (tirzepatide) offers the highest average weight reduction in clinical trials but requires careful dose escalation from 2.5mg to a maintenance dose of 5mg, 10mg, or 15mg depending on individual response and tolerability [2]. The once-weekly KwikPen device simplifies administration, and most patients reach their maintenance dose within 16-20 weeks.

Wegovy (semaglutide) follows a similar escalation schedule, starting at 0.25mg weekly and increasing gradually to the 2.4mg maintenance dose over 16-20 weeks [3]. This medication suits patients who prefer once-weekly dosing and have shown good response to GLP-1 therapy. Wegovy is also now available as an oral tablet formulation for those who prefer not to inject, though absorption rates differ slightly from the injectable form.

Saxenda (liraglutide) requires daily subcutaneous injection, starting at 0.6mg and escalating to 3mg over five weeks [4]. The daily dosing schedule provides more frequent appetite control but demands greater commitment to routine. Saxenda may be preferred for patients who respond well to shorter-acting GLP-1 medications or who have previously used liraglutide for diabetes management.

Which Injection Is Right for You?

Your UK prescriber will assess your BMI, medical history, current medications, and weight loss goals during your online consultation. Patients with a BMI of 30 or above (or 27 with weight-related health conditions) may be suitable for GLP-1 therapy, subject to clinical assessment [1]. Those seeking maximum weight reduction and willing to commit to a structured escalation programme may benefit most from tirzepatide, whilst patients preferring established treatments with extensive real-world data often choose semaglutide.

Clinical Evidence Behind Private Weight Loss Injections

The SURMOUNT clinical trial programme evaluated tirzepatide across diverse patient populations. SURMOUNT-1 enrolled 2,539 adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. At 72 weeks, 89% of participants on tirzepatide 15mg achieved at least 5% weight loss, compared to 28% on placebo [2]. Importantly, 57% achieved ≥20% weight reduction, a threshold rarely seen with earlier pharmacological interventions.

The STEP programme for semaglutide demonstrated robust efficacy across four major trials. STEP 1 showed that 86.4% of participants on semaglutide 2.4mg achieved ≥5% weight loss versus 31.5% on placebo [3]. STEP 2 specifically examined patients with type 2 diabetes, confirming dual benefits of glycaemic control and weight reduction. These trials informed NICE guidance and MHRA licensing decisions for semaglutide's weight management indication.

Long-term safety data spanning up to four years shows GLP-1 medications maintain weight loss with continued use, though weight regain occurs if treatment stops [5]. Common side effects include nausea (reported in 20-44% of participants), diarrhoea, and constipation, typically mild to moderate and diminishing over time [2][3]. Serious adverse events remain rare, with pancreatitis occurring in <0.2% of trial participants across all GLP-1 studies.

Real-World Outcomes in UK Clinical Practice

Post-marketing surveillance in the UK confirms trial findings translate to routine clinical practice. Patients adherent to prescribed dosing schedules and lifestyle modifications achieve weight reductions comparable to trial data, whilst those discontinuing prematurely see diminished results [5]. Our clinical team at Cured Pharmacy monitors patient progress through follow-up consultations, adjusting doses and providing support to optimise outcomes whilst minimising side effects.

How to Buy Private Weight Loss Injections Online UK Safely

Purchasing prescription weight loss injections requires clinical assessment by a UK-registered prescriber, as mandated by the Medicines and Healthcare products Regulatory Agency (MHRA). At Cured Pharmacy (GPhC registration 9012511), our process begins with a comprehensive online questionnaire covering your medical history, current medications, allergies, and weight loss goals. This typically takes under three minutes to complete.

Our UK-registered prescribers review your assessment within hours, not days. If clinically appropriate, they issue a prescription and determine your starting dose based on your individual profile. We dispense only genuine UK-licensed medications sourced through regulated wholesalers, never grey-market imports or compounded alternatives. Superintendent Pharmacist Tarun Kumar (GPhC 2233073) oversees all dispensing to ensure pharmaceutical quality and patient safety.

Delivery arrives in 100% discreet packaging with no external markings indicating contents. We provide detailed injection technique guides, dosing schedules, and side effect management advice with every order. Follow-up consultations remain free, allowing dose adjustments and clinical monitoring throughout your treatment journey. This comprehensive service model ensures you receive the same standard of care as traditional face-to-face consultations whilst benefiting from online convenience.

Pricing and Cost Comparison for Weight Loss Injections

At Cured Pharmacy, Mounjaro tirzepatide injections start from £135.00, representing competitive UK pricing for this advanced dual-receptor medication. Our transparent pricing model shows exact costs before you complete your consultation, eliminating surprise fees or hidden charges. The price reflects the licensed medication, clinical assessment, prescriber review, and discreet delivery to your chosen UK address.

We guarantee the lowest prices in the UK market across our weight loss injection range. Wegovy semaglutide injections start from £135.00, whilst Saxenda liraglutide begins at £135.00 for patients suitable for daily injection therapy. These prices include the complete service: online consultation, prescriber assessment, genuine UK-licensed medication, and delivery. Many patients find private online prescriptions cost-effective compared to repeated GP appointments and pharmacy collection visits.

Monthly costs vary depending on your prescribed maintenance dose. A patient on Mounjaro 10mg weekly will require different quantities than someone on the 2.5mg starter dose. Our clinical team calculates your monthly supply during consultation, providing clear cost projections for your entire treatment course. We also offer subscription options for ongoing treatment, ensuring you never run out whilst maintaining consistent monthly budgeting.

Insurance and NHS Availability

Weight loss injections remain limited on NHS prescription, with strict eligibility criteria typically requiring specialist referral and participation in tier 3 weight management services [6]. Private prescription through registered online pharmacies like Cured offers immediate access for patients meeting clinical criteria but unable to access NHS pathways. Some private health insurance policies cover GLP-1 medications for weight management when prescribed for obesity with comorbidities, though coverage varies significantly between providers.

Starting Your Weight Loss Injection Treatment

Begin by completing our online medical questionnaire, accessible 24/7 through the Cured Pharmacy website. You'll answer questions about your current weight, height, medical conditions, medications, and previous weight loss attempts. Be thorough and honest—our prescribers need complete information to assess your suitability safely. The questionnaire uses conditional logic, so you'll only see questions relevant to your answers, keeping completion time under three minutes.

Once submitted, a UK-registered prescriber reviews your assessment, typically within the same working day. If approved, you'll receive notification via email and SMS, with your prescription processed immediately. We dispatch orders Monday through Friday, with delivery typically arriving within 2-4 working days via tracked courier. Your package includes the prescribed medication, injection supplies (needles, alcohol wipes), comprehensive administration instructions, and our direct pharmacy contact line for questions.

Your first injection should follow the prescriber's specific instructions regarding timing, injection site rotation (abdomen, thigh, or upper arm), and dose. Most patients start on the lowest dose to minimise gastrointestinal side effects whilst their body adjusts to the medication. You'll escalate doses every four weeks according to your personalised schedule, which we provide in writing. Our clinical team remains available throughout treatment for dose adjustments, side effect management, and general support via phone, email, or follow-up consultation.

Maximising Results with Lifestyle Modifications

GLP-1 injections work most effectively when combined with reduced-calorie nutrition and increased physical activity [2][3]. The medications reduce appetite, making dietary adherence easier, but they don't replace the need for sustainable lifestyle changes. Our prescribers recommend aiming for a 500-750 calorie daily deficit through balanced nutrition and incorporating 150 minutes of moderate-intensity activity weekly, as per NICE guidelines for weight management [6]. This integrated approach optimises weight loss whilst building habits for long-term weight maintenance.

Scientific References

1. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72-130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
6. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to prescribed treatment, lifestyle modifications, and individual metabolic factors.